New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (654)	7/28/2003 9:57:44 AM
From: richardred	of 724

CHARLOTTE, N.C., July 28 /PRNewswire-FirstCall/ -- SPX Corporation (NYSE: SPW) today announced second quarter 2003 financial results of $1.27 billion in revenues, diluted earnings per share from continuing operations of $0.66, and free cash flow from continuing operations of $99.0 million. Commenting on the company's results, John B. Blystone, Chairman, President and CEO said, "We remain focused on building strategic platforms for profitable growth and cash flow generation, as evidenced by the recent sales of Inrange Technologies and our interest in the Assa Abloy door joint venture. Kendro, the primary business in the laboratory and life sciences platform, and EST, the building life-safety business, both grew organically mid-single-digits in the second quarter of 2003. These businesses experienced organic growth due to new product introductions and market share penetration despite very difficult market conditions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next